Clear Creek Financial Management »

Tg Therapeutics shares owned by Clear Creek Financial Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Clear Creek Financial Management from 13F filings

Historical chart of Clear Creek Financial Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Clear Creek Financial Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Clear Creek Financial Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $302k 20k 15.21
2023-12-31 $331k 19k 17.08
2023-09-30 $168k 20k 8.36

More positions owned by Clear Creek Financial Management

Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr S&p 500 Val Etf (IVE)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr S&p Mc 400gr Etf (IJK)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
NVIDIA Corporation (NVDA)
Simplify Exchange Traded Fun Managed Futures (CTA)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)

View all positions for Clear Creek Financial Management

Top funds holding Tg Therapeutics

Vanguard Group
Darwin Global Management
Millennium Management
Wellington Management Company
Opaleye Management
Paradigm Biocapital Advisors
683 Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Norges Bank Investment Management
Marshall Wace
Gts Securities
Soleus Capital Management
Jane Street

View all funds holding Tg Therapeutics